The medication works best when combined with healthy eating and regular physical activity
March 2022: Gallbladder disease is reported in some GLP-1 trials and added to Ozempics label
Guo M, Gu J, Teng F et al (2020) The efficacy and safety of combinations of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of type 2 diabetes or obese adults: a systematic review and meta-analysis
This safety profile, often highlighted in positive reviews, ensures that users can enjoy the benefits of ColonBroom without the worry of jitters, energy crashes, or disrupted sleep
If we can figure out what makes people worse, then we will maybe be able to figure out how to make people better from a more mechanistic standpoint, because there are very few drugs to treat chemotherapy-induced peripheral neuropathy. An obvious concern from the trials findings is that ALC may somehow potentiate the neurotoxic effects of taxanes